Genetic Signatures

Australian Exchange

Genetic Signatures, Microba Life Sciences in preliminary merger talks
ByChenos Kahn August 26, 2026August 26, 2026

SYDNEY: Genetic Signatures Limited and Microba Life Sciences Limited are in preliminary discussions about a potential merger that would create a leading infectious disease diagnostics group, the companies announced Wednesday. The proposed combination would unite Genetic Signatures’ regulatory-approved infectious disease…

Read More Genetic Signatures, Microba Life Sciences in preliminary merger talks
Australian Exchange

BCAL Diagnostics acquires 10.2% stake in Genetic Signatures for $1.4 million
ByChenos Kahn July 2, 2026July 2, 2026

SYDNEY: BCAL Diagnostics Ltd., an Australian healthcare company focused on early cancer detection, announced Thursday it has acquired a 10.2% stake in Genetic Signatures Ltd., a molecular diagnostics firm specializing in infectious disease testing. The all-cash transaction is valued at approximately $1.39 million….

Read More BCAL Diagnostics acquires 10.2% stake in Genetic Signatures for $1.4 million